ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Psychemedics Corporation (PMD) Report Updated: Feb 20, 2017 | Print This Page

Get more stock ratings by Louis Navellier

Psychemedics Corporation (PMD)

Rating: Buy Volatility: Moderate
Total Grade: B Industry: Health Care Providers & Services
Competitors: AMS,SSY,WCG,AIQ

Stock Analysis

Rating: Monthly View

A
B
C
D
F
February March April May June July August September October November December January

Rating: Weekly View

This Week: B down downgrade
Last Week: A same no change
Two Weeks Ago: A up no change
service keys

Psychemedics Corporation© quotemedia

Company Profile

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company’s testing methods utilize a patented technology that focuses on digesting hair and releasing drugs trapped in the hair without destroying the drugs. The company’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, and codeine. Psychemedics Corporation offers its services to employers for applicant and employee testing; physicians, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children’s drug use; and Fortune 500 companies and small to mid-size corporations. The company was founded in 1985 and is headquartered in Acton, Massachusetts.